politics
FDA reviewing safety of abortion drug mifepristone
Why this matters: political developments that affect policy direction and public trust.
The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to an administration official. The move marks a victory for anti-abortion groups that could pave the way for the Trump administration to restrict its use and how it can be distrib
Read full story on The Hill → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from The Hill alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop